Australia’s lung cancer program crosses new distance

July is set to mark the first anniversary of the National Lung Cancer Screening Program, Australia’s first national cancer screening initiative in more than two decades. It is a significant milestone that is defined by the ongoing work of delivery across distance, infrastructure, and clinical coordination.

This Health Industry Hub podcast episode brings together two perspectives working from different angles to support the success of the program.

On the operational and technical front, the conversation features Ewan Wylie, Respiratory Scientist & Head of BD at Heart of Australia, whose work focuses on the delivery and expansion of mobile respiratory diagnostics into remote communities. Complementing this, Vanessa Johnson, Head of Specialty Care for Lung Health at Boehringer Ingelheim, brings a broader strategic lens through the company particularly around partnerships, system-wide impact, and the longer-term goal of improving lung health equity.

At the centre of the discussion sits the arrival of HEART 8 and the partnerships that make it possible for advanced imaging and respiratory diagnostics to move across vast distances, crossing not just geographic borders, but the structural ones that have long shaped who receives specialist care and when.

The conversation further expands into the practical realities behind that model and what it actually takes to bring advanced health technologies into remote communities, and how early signals from the first year of the screening program are beginning to reflect its intended promise.

In reimagining healthcare across the entire patient journey, Health Industry Hub^TM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry Hub^TM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.